CXCR4 has been shown to regulate this EMT change in MM as well as homing to the BM, indicating several methods in which BTK inhibition can sensitize MM cells by disrupting the interaction of plasma cells with the BM stroma [6]. The gene discussed is CXCR4; the disease is Miyoshi myopathy.